Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Thrombocytopenia Clinical Trials
Thrombocytopenia clinical trials are recruiting across 67 cities. Here are the cities with the most active studies:
Thrombocytopenia Trial Phases
21 research organizations are sponsoring thrombocytopenia trials.
About Thrombocytopenia
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
Clinical trials are advancing new treatments for thrombocytopenia. Currently, 22 studies are recruiting a combined 4,579 participants across the United States. Research is being conducted by 21 organizations including NICHD Neonatal Research Network, Methodist Health System, Karolinska Institutet and 18 others.
2026 Thrombocytopenia Research Landscape
As of July 2026, the thrombocytopenia clinical trial landscape includes 22 actively recruiting studies across 67 cities in the United States. These studies are collectively seeking 4,579 participants, with an average enrollment target of 208 per study.
The research spans multiple phases of development: 7 studies are in PHASE3, 6 studies are in PHASE2, 3 studies are in PHASE1, 1 study is in NA, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some thrombocytopenia treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 21 different organizations, including NICHD Neonatal Research Network, Methodist Health System, Karolinska Institutet, Takeda, Novartis Pharmaceuticals, and 16 others. The large number of sponsors reflects significant research interest and investment in thrombocytopenia treatment advancement.
Geographically, thrombocytopenia trials are most concentrated in Boston, Massachusetts (9 trials); Los Angeles, California (7 trials); Iowa City, Iowa (5 trials); Rochester, New York (4 trials); Washington D.C., District of Columbia (4 trials) and 7 other cities.
Featured Thrombocytopenia Studies
Highlighted recruiting studies for thrombocytopenia, selected by enrollment size and research scope.
Neonatal Platelet Transfusion Threshold Trial
The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
The use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as markers of bleeding risk in thrombocytopenic preterm neonates admitted to the Neonatal Intensive Care Unit.
Frequently Asked Questions About Thrombocytopenia Clinical Trials
Are there thrombocytopenia clinical trials near me?
Yes, there are 22 thrombocytopenia clinical trials currently recruiting across 67+ cities in the United States, including Boston, Massachusetts; Los Angeles, California; Iowa City, Iowa. Browse the studies above to find one at a location convenient for you.
How do I join a thrombocytopenia clinical trial?
To join a thrombocytopenia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are thrombocytopenia clinical trials free?
Yes, participation in thrombocytopenia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of thrombocytopenia treatments are being studied?
Current thrombocytopenia clinical trials are testing a range of approaches across PHASE3 (7 studies), PHASE2 (6 studies), PHASE1 (3 studies), NA (1 study), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 21 research organizations.
Is it safe to participate in thrombocytopenia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov